| Freda L Ready, MD | |
|
Us Hwy 491 North, Shiprock, NM 87420 | |
| (505) 368-6001 | |
| Not Available |
| Full Name | Freda L Ready |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 10 Years |
| Location | Us Hwy 491 North, Shiprock, New Mexico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841601242 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD2020-0649 (New Mexico) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dhhs Phs Naihs Shiprock Hospital | 0749193837 | 93 |
News Archive
Hospira, the world's leading provider of injectable drugs and infusion technologies, today released an important enhancement to its TheraDoc clinical surveillance system designed to support hospital antimicrobial stewardship efforts, with the goal of helping to improve patient outcomes, reduce antimicrobial resistant infections and reduce costs.
Masimo, the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, announced today the full market release of its latest medical technology breakthrough—Masimo Rainbow Acoustic Monitoring— providing continuous and noninvasive respiration rate that is accurate, easy-to-use, and enhances patient tolerance.
The targeted drug trastuzumab, or Herceptin, previously shown to prolong survival in advanced breast cancer, dramatically reduced the chances of recurrence in patients with early-stage disease when given for one year following standard chemotherapy.
Scientists are now uncovering increasing evidence that the brain not only responds to hormones produced by the reproductive system, but that these hormones-the so-called "female hormones," estrogen and progestin, and the "male" androgens, such as testosterone-play an important role in the development of differences between male and female brains.
› Verified 3 days ago
| Entity Name | Dhhs Phs Naihs Shiprock Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780639971 PECOS PAC ID: 0749193837 Enrollment ID: O20031105000809 |
News Archive
Hospira, the world's leading provider of injectable drugs and infusion technologies, today released an important enhancement to its TheraDoc clinical surveillance system designed to support hospital antimicrobial stewardship efforts, with the goal of helping to improve patient outcomes, reduce antimicrobial resistant infections and reduce costs.
Masimo, the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, announced today the full market release of its latest medical technology breakthrough—Masimo Rainbow Acoustic Monitoring— providing continuous and noninvasive respiration rate that is accurate, easy-to-use, and enhances patient tolerance.
The targeted drug trastuzumab, or Herceptin, previously shown to prolong survival in advanced breast cancer, dramatically reduced the chances of recurrence in patients with early-stage disease when given for one year following standard chemotherapy.
Scientists are now uncovering increasing evidence that the brain not only responds to hormones produced by the reproductive system, but that these hormones-the so-called "female hormones," estrogen and progestin, and the "male" androgens, such as testosterone-play an important role in the development of differences between male and female brains.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Freda L Ready, MD Po Box 160, Shiprock, NM 87420-0160 Ph: (505) 368-6001 | Freda L Ready, MD Us Hwy 491 North, Shiprock, NM 87420 Ph: (505) 368-6001 |
News Archive
Hospira, the world's leading provider of injectable drugs and infusion technologies, today released an important enhancement to its TheraDoc clinical surveillance system designed to support hospital antimicrobial stewardship efforts, with the goal of helping to improve patient outcomes, reduce antimicrobial resistant infections and reduce costs.
Masimo, the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, announced today the full market release of its latest medical technology breakthrough—Masimo Rainbow Acoustic Monitoring— providing continuous and noninvasive respiration rate that is accurate, easy-to-use, and enhances patient tolerance.
The targeted drug trastuzumab, or Herceptin, previously shown to prolong survival in advanced breast cancer, dramatically reduced the chances of recurrence in patients with early-stage disease when given for one year following standard chemotherapy.
Scientists are now uncovering increasing evidence that the brain not only responds to hormones produced by the reproductive system, but that these hormones-the so-called "female hormones," estrogen and progestin, and the "male" androgens, such as testosterone-play an important role in the development of differences between male and female brains.
› Verified 3 days ago
Dr. Eve Solange Bruneau, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: Us Highway 491 North, Shiprock, NM 87420 Phone: 917-837-4535 | |
Dr. John C D'emilia, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: Us Hwy 491 North, Shiprock, NM 87420 Phone: 505-368-6001 | |
Franklin M Wolf, MD Surgery Medicare: Medicare Enrolled Practice Location: Us Hwy 491 North, Shiprock, NM 87420 Phone: 505-368-6401 Fax: 505-368-6431 | |
Sara Saad El-dein, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: Us Hwy 491 N, Shiprock, NM 87420 Phone: 505-368-6986 Fax: 505-368-6025 | |
James Stanley Rogers, MD Surgery Medicare: Medicare Enrolled Practice Location: Us Highway 491 N, Shiprock, NM 87420 Phone: 505-368-6401 Fax: 505-368-6431 | |
Susana B Samaniego, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: Us Hwy 491 North, Shiprock, NM 87420 Phone: 505-368-6001 |